{"nct_id":"NCT02821000","title":"Safety and Efficacy Study of Pembrolizumab (MK-3475) in Chinese Participants With Locally Advanced or Metastatic Melanoma (MK-3475-151/KEYNOTE-151)","status":"COMPLETED","status_verified_date":"2023-12","start_date":"2016-07-08","start_date_type":"ACTUAL","primary_completion_date":"2017-12-27","primary_completion_date_type":"ACTUAL","completion_date":"2022-11-30","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["MRK"]}